
Discovery Life Sciences Acquires ReachBio Research Labs
"We share Discovery's passion for science and believe that combining our expertise in cell-based assays and drug screening with Discovery's broad multi-omics capabilities will enable us to provide a broader and more strategic range of services to clients in the pharmaceutical industry."
- Emer Clarke, CSO ReachBio
Discover
Services
Our use of primary cell systems allows us to provide our clients with more predictable and clinically-relevant assays.
Products
Extensive knowledge allows us to provide high quality primary cells from bone marrow and peripheral blood.



Partner
PLATFORMSSCIENTIFIC POSTERS

September 27

Impact of Monoclonal Antibody (MoAb), Payload and Linker ...
March 8

Reliable and Predictive In Vitro Assays for Myelotoxicity ...
November 12
Looking for more? View all posts